Searched for
ASTRAZENECA COVID VACCINE
What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...- Covishield Side Effects: What's TTS syndrome, symptoms, and danger signs you shouldn't ignoreCovishield TTS: AstraZeneca has acknowledged the potential TTS side effects from its COVID-19 vaccine Covishield, used widely in India. TTS...
- Covishield Vaccine Case: AstraZeneca expresses 'sympathy' for those who lost loved onesCovishield Vaccine Row: Following AstraZeneca's acknowledgment of a rare side effect associated with its COVID-19 vaccine, known as Covishi...
- Study links AstraZeneca's Covid vaccine to higher risk of very rare clotSeveral countries have already altered their advice after previous research indicated that, in rare number of cases, thrombosis with thromb...
- AstraZeneca Covid booster shot effective against severe disease, UK study findsThe researchers from the UK Health Security Agency, London, estimated vaccine effectiveness by analysing data on all adults aged 18 years a...
- RDIF says early results of 'mix & match' of Sputnik Light, AstraZeneca jab found to be safeAstraZeneca COVID vaccine is the same as Covishield which is used in India and several other countries.
- AstraZeneca pulls request for Swiss approval of COVID-19 shotSwitzerland has cleared the BioNTech-Pfizer, Moderna and Johnson & Johnson vaccines for use. However, national medical regulator Swissmedic...
- India likely to allow smaller gap between AstraZeneca COVID vaccine doses sold privately: SourcesEarlier this month, the high court in Kerala ordered changes in the health ministry's vaccine-booking platform to give people paying for va...
- COVID: AstraZeneca pledges $250,000 as humanitarian aid to IndiaThe aid to India is part of the USD 1 million which the British-Swedish multinational has earmarked for relief initiatives across communiti...
- One AstraZeneca Covid vaccine dose gives 80% lower death risk: English dataThe study looked at new symptomatic cases of COVID-19 between December and April and people who died within 28 days of their positive test ...
- UK scientists find higher risk of brain clots from COVID-19 compared with vaccinesA study of 500,000 COVID-19 patients found CVST had occurred at a rate of 39 people out of a million following infection, researchers said....
- Hong Kong govt to delay imports of AstraZeneca vaccine amid safety concernsHealth Secretary Sophia Chan said the global financial centre had a sufficient supply of vaccines, with a total of 15 million doses of Germ...
- AstraZeneca woes grow as Australia, Philippines, African Union curb COVID-19 shotsThe vaccine - developed with Oxford University and considered a frontrunner in the global vaccine race - has been plagued by safety concern...
- WHO gives nod to AstraZeneca vaccine and its 'tremendous potential'"The AstraZeneca COVID-19 vaccine (including Covishield) continues to have a positive benefit-risk profile, with tremendous potential to pr...
- Brazil gives final approval for AstraZeneca vaccine, sees domestic manufactureThe AstraZeneca vaccine is already being administered in Brazil, but is registered only for emergency use, and the doses have been imported...
- Astrazeneca Covid vaccine gets approval in Pakistan: Health minister"DRAP granted emergency use authorisation to AstraZeneca's Covid vaccine," Pakistan's Health Minister Faisal Sultan told Reuters, referring...
- Oxford/AstraZeneca in ‘mix-match' COVID-19 vaccine trial with Russia's SputnikThe two sets of experts are to join forces to explore if a combination of the two jabs, both using a benign virus called adenovirus, could ...
- AstraZeneca must prove claim to cheapest COVID-19 vaccine: MSFThe British firm said on Monday its COVID-19 vaccine was 70% effective in pivotal trials and could be up to 90% effective, giving the world...
- Serum Institute of India officially halts the trial of Astrazeneca-Oxford vaccine in India"We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. We are following DCGI's instructions and wil...
- India trials of COVID-19 vaccine is going on: Serum InstituteLast month, the Drug Controller General of India had granted permission to the Pune-based SII to conduct Phase-II and -III human clinical t...
Load More
